Normal view MARC view ISBD view

Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society

TextReference number:PUB11021 In: Journal of Clinical Endocrinology and Metabolism 86 (5), 1868-1870.

Reviews from LibraryThing.com:

Tags from this library: No tags from this library for this title. Log in to add tags.

Holdings
Item type	Current library	Collection	Class number	Copy number	Status	Date due	Barcode	Item reservations
Magazine	Staff publications New Materials Shelf	Non-fiction	XX(11120.1) (Browse shelf(Opens below))	1	Available		11120-1001

Total reservations: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	XX(11117.1) Effects of atypical allosteric agents on the binding of [H- 3]dimethyl-W84 to M-2 receptors	XX(11118.1) Identification of the regions of Fv1 necessary for murine leukemia virus restriction	XX(11119.1) Evidence that the testis determination pathway interacts with a non-dosage compensated, X-linked gene	XX(11120.1) Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society	XX(11121.1) Vav1 regulates phospholipase Cg activation and calcium responses in mast cells	XX(11122.1) Olfactory ensheathing cells - another miracle cure for spinal cord injury?	XX(11123.1) Generation of transchromosomal mice using ES cells containing freely segregating fragments of HSA21; a model for human Down syndrome	Next

There are no comments on this title.

to post a comment.

PTFS Europe